Global Point-Of-Care Or Rapid Diagnostics Supply, Demand and Key Producers, 2026-2032
1 Supply Summary
- 1.1 Point-Of-Care Or Rapid Diagnostics Introduction
- 1.2 World Point-Of-Care Or Rapid Diagnostics Supply & Forecast
- 1.2.1 World Point-Of-Care Or Rapid Diagnostics Production Value (2021 & 2025 & 2032)
- 1.2.2 World Point-Of-Care Or Rapid Diagnostics Production (2021-2032)
- 1.2.3 World Point-Of-Care Or Rapid Diagnostics Pricing Trends (2021-2032)
- 1.3 World Point-Of-Care Or Rapid Diagnostics Production by Region (Based on Production Site)
- 1.3.1 World Point-Of-Care Or Rapid Diagnostics Production Value by Region (2021-2032)
- 1.3.2 World Point-Of-Care Or Rapid Diagnostics Production by Region (2021-2032)
- 1.3.3 World Point-Of-Care Or Rapid Diagnostics Average Price by Region (2021-2032)
- 1.3.4 North America Point-Of-Care Or Rapid Diagnostics Production (2021-2032)
- 1.3.5 Europe Point-Of-Care Or Rapid Diagnostics Production (2021-2032)
- 1.3.6 Japan Point-Of-Care Or Rapid Diagnostics Production (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Point-Of-Care Or Rapid Diagnostics Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Point-Of-Care Or Rapid Diagnostics Major Market Trends
2 Demand Summary
- 2.1 World Point-Of-Care Or Rapid Diagnostics Demand (2021-2032)
- 2.2 World Point-Of-Care Or Rapid Diagnostics Consumption by Region
- 2.2.1 World Point-Of-Care Or Rapid Diagnostics Consumption by Region (2021-2026)
- 2.2.2 World Point-Of-Care Or Rapid Diagnostics Consumption Forecast by Region (2027-2032)
- 2.3 United States Point-Of-Care Or Rapid Diagnostics Consumption (2021-2032)
- 2.4 China Point-Of-Care Or Rapid Diagnostics Consumption (2021-2032)
- 2.5 Europe Point-Of-Care Or Rapid Diagnostics Consumption (2021-2032)
- 2.6 Japan Point-Of-Care Or Rapid Diagnostics Consumption (2021-2032)
- 2.7 South Korea Point-Of-Care Or Rapid Diagnostics Consumption (2021-2032)
- 2.8 ASEAN Point-Of-Care Or Rapid Diagnostics Consumption (2021-2032)
- 2.9 India Point-Of-Care Or Rapid Diagnostics Consumption (2021-2032)
3 World Manufacturers Competitive Analysis
- 3.1 World Point-Of-Care Or Rapid Diagnostics Production Value by Manufacturer (2021-2026)
- 3.2 World Point-Of-Care Or Rapid Diagnostics Production by Manufacturer (2021-2026)
- 3.3 World Point-Of-Care Or Rapid Diagnostics Average Price by Manufacturer (2021-2026)
- 3.4 Point-Of-Care Or Rapid Diagnostics Company Evaluation Quadrant
- 3.5 Industry Rank and Concentration Rate (CR)
- 3.5.1 Global Point-Of-Care Or Rapid Diagnostics Industry Rank of Major Manufacturers
- 3.5.2 Global Concentration Ratios (CR4) for Point-Of-Care Or Rapid Diagnostics in 2025
- 3.5.3 Global Concentration Ratios (CR8) for Point-Of-Care Or Rapid Diagnostics in 2025
- 3.6 Point-Of-Care Or Rapid Diagnostics Market: Overall Company Footprint Analysis
- 3.6.1 Point-Of-Care Or Rapid Diagnostics Market: Region Footprint
- 3.6.2 Point-Of-Care Or Rapid Diagnostics Market: Company Product Type Footprint
- 3.6.3 Point-Of-Care Or Rapid Diagnostics Market: Company Product Application Footprint
- 3.7 Competitive Environment
- 3.7.1 Historical Structure of the Industry
- 3.7.2 Barriers of Market Entry
- 3.7.3 Factors of Competition
- 3.8 New Entrant and Capacity Expansion Plans
- 3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
- 4.1 United States VS China: Point-Of-Care Or Rapid Diagnostics Production Value Comparison
- 4.1.1 United States VS China: Point-Of-Care Or Rapid Diagnostics Production Value Comparison (2021 & 2025 & 2032)
- 4.1.2 United States VS China: Point-Of-Care Or Rapid Diagnostics Production Value Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States VS China: Point-Of-Care Or Rapid Diagnostics Production Comparison
- 4.2.1 United States VS China: Point-Of-Care Or Rapid Diagnostics Production Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Point-Of-Care Or Rapid Diagnostics Production Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States VS China: Point-Of-Care Or Rapid Diagnostics Consumption Comparison
- 4.3.1 United States VS China: Point-Of-Care Or Rapid Diagnostics Consumption Comparison (2021 & 2025 & 2032)
- 4.3.2 United States VS China: Point-Of-Care Or Rapid Diagnostics Consumption Market Share Comparison (2021 & 2025 & 2032)
- 4.4 United States Based Point-Of-Care Or Rapid Diagnostics Manufacturers and Market Share, 2021-2026
- 4.4.1 United States Based Point-Of-Care Or Rapid Diagnostics Manufacturers, Headquarters and Production Site (States, Country)
- 4.4.2 United States Based Manufacturers Point-Of-Care Or Rapid Diagnostics Production Value (2021-2026)
- 4.4.3 United States Based Manufacturers Point-Of-Care Or Rapid Diagnostics Production (2021-2026)
- 4.5 China Based Point-Of-Care Or Rapid Diagnostics Manufacturers and Market Share
- 4.5.1 China Based Point-Of-Care Or Rapid Diagnostics Manufacturers, Headquarters and Production Site (Province, Country)
- 4.5.2 China Based Manufacturers Point-Of-Care Or Rapid Diagnostics Production Value (2021-2026)
- 4.5.3 China Based Manufacturers Point-Of-Care Or Rapid Diagnostics Production (2021-2026)
- 4.6 Rest of World Based Point-Of-Care Or Rapid Diagnostics Manufacturers and Market Share, 2021-2026
- 4.6.1 Rest of World Based Point-Of-Care Or Rapid Diagnostics Manufacturers, Headquarters and Production Site (State, Country)
- 4.6.2 Rest of World Based Manufacturers Point-Of-Care Or Rapid Diagnostics Production Value (2021-2026)
- 4.6.3 Rest of World Based Manufacturers Point-Of-Care Or Rapid Diagnostics Production (2021-2026)
5 Market Analysis by Type
- 5.1 World Point-Of-Care Or Rapid Diagnostics Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 Blood Glucose Testing
- 5.2.2 Infectious Diseases Testing
- 5.2.3 Cardiac Markers Testing
- 5.2.4 Coagulation Testing
- 5.2.5 Pregnancy and Fertility Testing
- 5.2.6 Blood Gas/Electrolytes Testing
- 5.2.7 Urinalysis Testing
- 5.2.8 Other
- 5.3 Market Segment by Type
- 5.3.1 World Point-Of-Care Or Rapid Diagnostics Production by Type (2021-2032)
- 5.3.2 World Point-Of-Care Or Rapid Diagnostics Production Value by Type (2021-2032)
- 5.3.3 World Point-Of-Care Or Rapid Diagnostics Average Price by Type (2021-2032)
6 Market Analysis by Application
- 6.1 World Point-Of-Care Or Rapid Diagnostics Market Size Overview by Application: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Application
- 6.2.1 Hospital
- 6.2.2 Clinic
- 6.2.3 Independent Laboratories
- 6.2.4 Others
- 6.3 Market Segment by Application
- 6.3.1 World Point-Of-Care Or Rapid Diagnostics Production by Application (2021-2032)
- 6.3.2 World Point-Of-Care Or Rapid Diagnostics Production Value by Application (2021-2032)
- 6.3.3 World Point-Of-Care Or Rapid Diagnostics Average Price by Application (2021-2032)
7 Company Profiles
- 7.1 Roche
- 7.1.1 Roche Details
- 7.1.2 Roche Major Business
- 7.1.3 Roche Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.1.4 Roche Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.1.5 Roche Recent Developments/Updates
- 7.1.6 Roche Competitive Strengths & Weaknesses
- 7.2 Abbott
- 7.2.1 Abbott Details
- 7.2.2 Abbott Major Business
- 7.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.2.5 Abbott Recent Developments/Updates
- 7.2.6 Abbott Competitive Strengths & Weaknesses
- 7.3 LifeScan
- 7.3.1 LifeScan Details
- 7.3.2 LifeScan Major Business
- 7.3.3 LifeScan Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.3.4 LifeScan Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.3.5 LifeScan Recent Developments/Updates
- 7.3.6 LifeScan Competitive Strengths & Weaknesses
- 7.4 Siemens Healthineers
- 7.4.1 Siemens Healthineers Details
- 7.4.2 Siemens Healthineers Major Business
- 7.4.3 Siemens Healthineers Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.4.4 Siemens Healthineers Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.4.5 Siemens Healthineers Recent Developments/Updates
- 7.4.6 Siemens Healthineers Competitive Strengths & Weaknesses
- 7.5 Danaher
- 7.5.1 Danaher Details
- 7.5.2 Danaher Major Business
- 7.5.3 Danaher Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.5.4 Danaher Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.5.5 Danaher Recent Developments/Updates
- 7.5.6 Danaher Competitive Strengths & Weaknesses
- 7.6 Ascensia
- 7.6.1 Ascensia Details
- 7.6.2 Ascensia Major Business
- 7.6.3 Ascensia Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.6.4 Ascensia Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.6.5 Ascensia Recent Developments/Updates
- 7.6.6 Ascensia Competitive Strengths & Weaknesses
- 7.7 BioMerieux
- 7.7.1 BioMerieux Details
- 7.7.2 BioMerieux Major Business
- 7.7.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.7.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.7.5 BioMerieux Recent Developments/Updates
- 7.7.6 BioMerieux Competitive Strengths & Weaknesses
- 7.8 ARKRAY
- 7.8.1 ARKRAY Details
- 7.8.2 ARKRAY Major Business
- 7.8.3 ARKRAY Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.8.4 ARKRAY Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.8.5 ARKRAY Recent Developments/Updates
- 7.8.6 ARKRAY Competitive Strengths & Weaknesses
- 7.9 Bio-Rad Laboratories
- 7.9.1 Bio-Rad Laboratories Details
- 7.9.2 Bio-Rad Laboratories Major Business
- 7.9.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.9.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.9.5 Bio-Rad Laboratories Recent Developments/Updates
- 7.9.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
- 7.10 Nova Biomedical
- 7.10.1 Nova Biomedical Details
- 7.10.2 Nova Biomedical Major Business
- 7.10.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.10.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.10.5 Nova Biomedical Recent Developments/Updates
- 7.10.6 Nova Biomedical Competitive Strengths & Weaknesses
- 7.11 QuidelOrtho
- 7.11.1 QuidelOrtho Details
- 7.11.2 QuidelOrtho Major Business
- 7.11.3 QuidelOrtho Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.11.4 QuidelOrtho Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.11.5 QuidelOrtho Recent Developments/Updates
- 7.11.6 QuidelOrtho Competitive Strengths & Weaknesses
- 7.12 Accriva
- 7.12.1 Accriva Details
- 7.12.2 Accriva Major Business
- 7.12.3 Accriva Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.12.4 Accriva Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.12.5 Accriva Recent Developments/Updates
- 7.12.6 Accriva Competitive Strengths & Weaknesses
- 7.13 OraSure Technologies
- 7.13.1 OraSure Technologies Details
- 7.13.2 OraSure Technologies Major Business
- 7.13.3 OraSure Technologies Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.13.4 OraSure Technologies Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.13.5 OraSure Technologies Recent Developments/Updates
- 7.13.6 OraSure Technologies Competitive Strengths & Weaknesses
- 7.14 Helena Laboratories
- 7.14.1 Helena Laboratories Details
- 7.14.2 Helena Laboratories Major Business
- 7.14.3 Helena Laboratories Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.14.4 Helena Laboratories Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.14.5 Helena Laboratories Recent Developments/Updates
- 7.14.6 Helena Laboratories Competitive Strengths & Weaknesses
- 7.15 Phamatech
- 7.15.1 Phamatech Details
- 7.15.2 Phamatech Major Business
- 7.15.3 Phamatech Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.15.4 Phamatech Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.15.5 Phamatech Recent Developments/Updates
- 7.15.6 Phamatech Competitive Strengths & Weaknesses
- 7.16 Chembio Diagnostics
- 7.16.1 Chembio Diagnostics Details
- 7.16.2 Chembio Diagnostics Major Business
- 7.16.3 Chembio Diagnostics Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.16.4 Chembio Diagnostics Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.16.5 Chembio Diagnostics Recent Developments/Updates
- 7.16.6 Chembio Diagnostics Competitive Strengths & Weaknesses
- 7.17 Trinity Biotech
- 7.17.1 Trinity Biotech Details
- 7.17.2 Trinity Biotech Major Business
- 7.17.3 Trinity Biotech Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.17.4 Trinity Biotech Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.17.5 Trinity Biotech Recent Developments/Updates
- 7.17.6 Trinity Biotech Competitive Strengths & Weaknesses
- 7.18 Wuhan Easy Diagnosis
- 7.18.1 Wuhan Easy Diagnosis Details
- 7.18.2 Wuhan Easy Diagnosis Major Business
- 7.18.3 Wuhan Easy Diagnosis Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.18.4 Wuhan Easy Diagnosis Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.18.5 Wuhan Easy Diagnosis Recent Developments/Updates
- 7.18.6 Wuhan Easy Diagnosis Competitive Strengths & Weaknesses
- 7.19 Intec PRODUCT
- 7.19.1 Intec PRODUCT Details
- 7.19.2 Intec PRODUCT Major Business
- 7.19.3 Intec PRODUCT Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.19.4 Intec PRODUCT Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.19.5 Intec PRODUCT Recent Developments/Updates
- 7.19.6 Intec PRODUCT Competitive Strengths & Weaknesses
- 7.20 Sinocare
- 7.20.1 Sinocare Details
- 7.20.2 Sinocare Major Business
- 7.20.3 Sinocare Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.20.4 Sinocare Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.20.5 Sinocare Recent Developments/Updates
- 7.20.6 Sinocare Competitive Strengths & Weaknesses
- 7.21 Wondfo
- 7.21.1 Wondfo Details
- 7.21.2 Wondfo Major Business
- 7.21.3 Wondfo Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.21.4 Wondfo Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.21.5 Wondfo Recent Developments/Updates
- 7.21.6 Wondfo Competitive Strengths & Weaknesses
- 7.22 Getein Biotech
- 7.22.1 Getein Biotech Details
- 7.22.2 Getein Biotech Major Business
- 7.22.3 Getein Biotech Point-Of-Care Or Rapid Diagnostics Product and Services
- 7.22.4 Getein Biotech Point-Of-Care Or Rapid Diagnostics Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.22.5 Getein Biotech Recent Developments/Updates
- 7.22.6 Getein Biotech Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Point-Of-Care Or Rapid Diagnostics Industry Chain
- 8.2 Point-Of-Care Or Rapid Diagnostics Upstream Analysis
- 8.2.1 Point-Of-Care Or Rapid Diagnostics Core Raw Materials
- 8.2.2 Main Manufacturers of Point-Of-Care Or Rapid Diagnostics Core Raw Materials
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis
- 8.5 Point-Of-Care Or Rapid Diagnostics Production Mode
- 8.6 Point-Of-Care Or Rapid Diagnostics Procurement Model
- 8.7 Point-Of-Care Or Rapid Diagnostics Industry Sales Model and Sales Channels
- 8.7.1 Point-Of-Care Or Rapid Diagnostics Sales Model
- 8.7.2 Point-Of-Care Or Rapid Diagnostics Typical Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
The global Point-Of-Care Or Rapid Diagnostics market size is expected to reach $ 37020 million by 2032, rising at a market growth of 7.0% CAGR during the forecast period (2026-2032).
Point-of-care (POC) and Rapid Diagnostic is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
The Point of Care and Rapid Diagnostic market is primarily driven by the rising demand for rapid and accessible diagnostic solutions. This demand is fueled by the need for quicker decision-making in healthcare, especially in remote or resource-constrained settings. Additionally, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is propelling the adoption of POCT devices for monitoring and early detection. Moreover, the emphasis on decentralized healthcare and patient-centric approaches is pushing the market to develop more user-friendly and efficient POCT solutions.
While the key challenges facing the POCT product and device market is the necessity for strict regulatory compliance and quality assurance. Ensuring that POCT devices meet regulatory standards and maintain accuracy and reliability is critical for patient safety and effective healthcare delivery. Additionally, challenges related to data management, connectivity, and integration with electronic health records need to be addressed to fully leverage the potential of POCT in improving healthcare outcomes. Balancing ease of use with regulatory compliance remains a pivotal challenge for manufacturers in this rapidly evolving market.
The major global manufacturers of Point of Care and Rapid Diagnostic include Abbott, Roche, Danaher, Siemens Healthineers, QuidelOrtho, LifeScan, Wondfo, BioMerieux, Ascensia, ARKRAY, etc. In 2023, the world's top five vendors accounted for approximately 73.47% of the revenue.
This report studies the global Point-Of-Care Or Rapid Diagnostics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Point-Of-Care Or Rapid Diagnostics and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point-Of-Care Or Rapid Diagnostics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Point-Of-Care Or Rapid Diagnostics total production and demand, 2021-2032, (M Units)
Global Point-Of-Care Or Rapid Diagnostics total production value, 2021-2032, (USD Million)
Global Point-Of-Care Or Rapid Diagnostics production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Point-Of-Care Or Rapid Diagnostics consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Point-Of-Care Or Rapid Diagnostics domestic production, consumption, key domestic manufacturers and share
Global Point-Of-Care Or Rapid Diagnostics production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Point-Of-Care Or Rapid Diagnostics production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Point-Of-Care Or Rapid Diagnostics production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Point-Of-Care Or Rapid Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY, Bio-Rad Laboratories, Nova Biomedical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point-Of-Care Or Rapid Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/K Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Point-Of-Care Or Rapid Diagnostics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Point-Of-Care Or Rapid Diagnostics Market, Segmentation by Type:
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Other
Global Point-Of-Care Or Rapid Diagnostics Market, Segmentation by Application:
Hospital
Clinic
Independent Laboratories
Others
Companies Profiled:
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Bio-Rad Laboratories
Nova Biomedical
QuidelOrtho
Accriva
OraSure Technologies
Helena Laboratories
Phamatech
Chembio Diagnostics
Trinity Biotech
Wuhan Easy Diagnosis
Intec PRODUCT
Sinocare
Wondfo
Getein Biotech
Key Questions Answered:
1. How big is the global Point-Of-Care Or Rapid Diagnostics market?
2. What is the demand of the global Point-Of-Care Or Rapid Diagnostics market?
3. What is the year over year growth of the global Point-Of-Care Or Rapid Diagnostics market?
4. What is the production and production value of the global Point-Of-Care Or Rapid Diagnostics market?
5. Who are the key producers in the global Point-Of-Care Or Rapid Diagnostics market?
6. What are the growth factors driving the market demand?